Cargando…
Novel Baicalein-Derived Inhibitors of Plasmodium falciparum
Malaria, a life-threatening mosquito-borne disease caused by Plasmodium parasites, continues to pose a significant global health burden. Despite notable progress in combating the disease in recent years, malaria remains prevalent in many regions, particularly in Southeast Asia and most of sub-Sahara...
Autores principales: | Gudla, Chandra Sekhar, Selvam, Vignesh, Selvaraj, Siva Shanmugam, Tripathi, Renu, Joshi, Prince, Shaham, Salique Hassan, Singh, Mayas, Shandil, Radha Krishan, Habib, Saman, Narayanan, Shridhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10610289/ https://www.ncbi.nlm.nih.gov/pubmed/37887758 http://dx.doi.org/10.3390/pathogens12101242 |
Ejemplares similares
-
Evaluation of the Therapeutic Potential of Mesenchymal Stem Cells (MSCs) in Preclinical Models of Autoimmune Diseases
por: Shandil, Radha Krishan, et al.
Publicado: (2022) -
Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria
por: Potluri, Vijay, et al.
Publicado: (2020) -
Genomic Mutations in SARS-CoV-2 Genome following Infection in Syrian Golden Hamster and Associated Lung Pathologies
por: Rudramurthy, Gudepalya Renukaiah, et al.
Publicado: (2023) -
Unravelling the Secrets of Mycobacterial Cidality through the Lens of Antisense
por: Kaur, Parvinder, et al.
Publicado: (2016) -
A Live Attenuated COVID-19 Candidate Vaccine for Children: Protection against SARS-CoV-2 Challenge in Hamsters
por: Mehla, Rajeev, et al.
Publicado: (2023)